• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Neal Cutler, M.D., honored with 2017 European CEO Award

Neal Cutler, M.D., honored with 2017 European CEO Award

May 22, 2017
CenterWatch Staff

Neal Cutler, M.D., chief executive officer of Worldwide Clinical Trials, has been named by the 2017 European CEO Awards as the “Best CEO in the CRO Industry.” This honor recognizes Dr. Cutler’s contributions as the founder and CEO of Worldwide, one of the world’s leading, full-service CROs. The annual European CEO Awards highlight the achievements of CEOs across a variety of industries whose contributions are driving their companies forward.

Dr. Cutler, a board-certified psychiatrist who is also board-qualified in both neurology and clinical pharmacology, has been instrumental in the design and clinical development of nearly 200 compounds in numerous therapeutic areas. Since creating the first iteration of Worldwide Clinical Trials 30 years ago, he has guided the company with a steadfast commitment to the medicine and science of clinical research, leading to impressive growth. This, along with his consistent dedication to Worldwide’s customers, were named as key reasons for his receiving the European CEO Award.

“I am humbled to have been recognized with this prestigious honor. This truly is a reflection of what Worldwide has achieved, and the high-quality service that we consistently deliver – I share this award with our amazing team,” said Dr. Cutler. “My passion for the potentially life-changing work Worldwide does every day drives me and shapes my leadership, and it is this passion that I share with our entire company. This drive to support our sponsor partners in drug discovery permeates our company and has helped build our reputation as one of the world’s leading CROs.”

Throughout his career, Dr. Cutler has been a prominent figure in the industry, having been invited to give hundreds of presentations around the world in the fields of aging, clinical pharmacology and drug development. Additionally, he has authored 276 publications, including nine books on the topics of clinical pharmacology, aging, Alzheimer’s disease, schizophrenia, anxiety disorders and diabetes.

The European CEO Awards recognize the leading players across a range of sectors, the companies pushing the envelope in business, and the executives who make this progress possible. Dr. Cutler joins other recent healthcare industry winners including the CEOs of Chronos Therapeutics, Biolingus, and Evaxion Biotech.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing